MAY 28, 2016 6:53 AM PDT

First Simultaneous Skull-Scalp, Kidney, and Pancreas Transplant

WRITTEN BY: Xuan Pham
In a medical first, doctors from Houston, Texas reported a simultaneous scalp, skull, kidney, and pancreas transplant from one donor to a recipient. The drastic, never-been-done-before procedure allowed a patient to reclaim better health outcomes that would otherwise not be possible. Additionally, doctors hope this medical case will open the door for more combined transplants in the future.
 
Texas man gets new skull-scalp transplant along with 2 organs
The recipient of this landmark procedure is a 55-year-old man who has type 1 diabetes. The patient underwent kidney and pancreas transplantation over 20 years ago, but the kidney organ is now failing. In 2005, the patient developed an aggressive cancer on his scalp that was successfully treated, but left him with a large, non-healing scalp wound that was prone to severe infections.
 
His team of doctors weighed their options to treat the multi-organ complications in this patient. They concluded that a scalp and skull transplant could be performed at the same time the kidney and pancreas transplant was taking place, provided the organs came from the same donor.
 
The scalp and skull transplantation is different than the solid organ transplant in that it involves connecting multiple types of tissues, like skin, muscle, blood vessels, nerves, and bone. Known as vascularized composite allotransplantation, or VCA, the procedure requires a lifelong need for immunosuppressive therapy to prevent rejection. Previous face and hand transplants proved the success of VCA, but doctors have not attempted to combine VCA with other organ transplants at the same time.
 
In the case of this diabetic patient who was already taking immunosuppressive medications, the scalp/skull VCA combined with the double organ transplant seemed a to be a viable measure to both the doctors and the patient.
 
It took 18 months to find a suitable deceased donor who matched the patient’s immune type, head size, skin color, and hair pattern. Then it took 20 surgeons 15 hours in the operating room to make the transplant a success.
 
Doctors noted the transplants received adequate blood supply and seemed to function normally. The patient experienced a brief episode of rejection with the scalp/skull transplant that was successfully thwarted. A year later, the patient is reported to be in good health, benefiting from his transplanted organs and the corrected defect on his skull.
 
 
"Hopefully, this case and others like it will help to widen the narrow indications for this fascinating new field of reconstructive surgery," said Jesse Creed Selber at the University of Texas M.D. Anderson Cancer Center, first author of the report.

Additional source: EurekAlert!, Plastics and Reconstructive Surgery Journal
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 07, 2019
Clinical & Molecular DX
AUG 07, 2019
Hepatitis A Causes Public Health Crisis In Florida
Although highly contagious, Hepatitis A is considered a rare disease. It has largely been controlled through immunizations. That said, in Florida, Hepatiti...
SEP 05, 2019
Clinical & Molecular DX
SEP 05, 2019
Muscular Dystrophy Drug by Sarepta Therapeutics: Approval or Rejection by Drug Regulating Authorities?
Duchenne Muscular Dystrophy (DMD is a rare, genetic disorder that hampers muscle movement and is the most common pediatric muscular dystrophy. I...
NOV 26, 2019
Immunology
NOV 26, 2019
The Immune System's Hand in Toxic Shock
While rare, toxic shock is a dangerous condition that acts fast and can be fatal. A new study identified a new target for treating toxic shock, a component...
DEC 23, 2019
Clinical & Molecular DX
DEC 23, 2019
Long awaited at-home test gives hemophiliacs peace of mind
Haemophilia is a genetically-inherited condition that severely affects an individual’s ability to stop bleeding. Blood clotting is a natural protecti...
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially in younger patients. It is paramou...
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
MicroRNA emerges as a biomarker for migraines
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience migraines, it’s frustrating t...
Loading Comments...